American International Group, Inc. Rocket Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$26.16 - $30.74 $6,958 - $8,176	-266 Reduced 0.85%	30,918 $832,000
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $53,427 - $101,696	3,184 Added 11.37%	31,184 $934,000
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $14,994 - $23,929	995 Added 3.68%	28,000 $573,000
Q2 2023 Aug 04, 2023	BUY	$16.59 - $23.6 $962 - $1,368	58 Added 0.22%	27,005 $536,000
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $24,142 - $34,555	1,529 Added 6.02%	26,947 $461,000
Q4 2022 Feb 10, 2023	BUY	$15.5 - $22.76 $71,966 - $105,674	4,643 Added 22.35%	25,418 $497,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $3,624 - $5,394	293 Added 1.43%	20,775 $332,000
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $87 - $183	11 Added 0.05%	20,482 $282,000
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $18,937 - $34,075	-1,439 Reduced 6.57%	20,471 $325,000
Q4 2021 Feb 11, 2022	SELL	$21.52 - $36.02 $7,897 - $13,219	-367 Reduced 1.65%	21,910 $478,000
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $493 - $881	18 Added 0.08%	22,277 $666,000
Q2 2021 Aug 13, 2021	BUY	$39.41 - $47.25 $18,404 - $22,065	467 Added 2.14%	22,259 $986,000
Q1 2021 May 07, 2021	BUY	$43.34 - $65.91 $86,289 - $131,226	1,991 Added 10.06%	21,792 $967,000
Q4 2020 Feb 12, 2021	SELL	$23.3 - $59.57 $13,234 - $33,835	-568 Reduced 2.79%	19,801 $1.09 Million
Q3 2020 Nov 04, 2020	SELL	$20.5 - $28.59 $9,512 - $13,265	-464 Reduced 2.23%	20,369 $466,000
Q2 2020 Aug 12, 2020	BUY	$13.32 - $22.61 $24,908 - $42,280	1,870 Added 9.86%	20,833 $436,000
Q1 2020 May 04, 2020	BUY	$9.71 - $25.11 $3,320 - $8,587	342 Added 1.84%	18,963 $265,000
Q4 2019 Feb 05, 2020	SELL	$11.07 - $24.23 $1,737 - $3,804	-157 Reduced 0.84%	18,621 $424,000
Q3 2019 Nov 08, 2019	SELL	$10.85 - $14.78 $1,421 - $1,936	-131 Reduced 0.69%	18,778 $219,000
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.81 $56,670 - $74,842	3,778 Added 24.97%	18,909 $284,000
Q1 2019 May 06, 2019	BUY	$13.45 - $19.01 $18,708 - $26,442	1,391 Added 10.12%	15,131 $265,000
Q4 2018 Feb 13, 2019	SELL	$11.21 - $23.53 $1,199 - $2,517	-107 Reduced 0.77%	13,740 $204,000
Q3 2018 Nov 09, 2018	BUY	$18.5 - $25.49 $4,643 - $6,397	251 Added 1.85%	13,847 $341,000
Q2 2018 Aug 08, 2018	BUY	$14.58 - $23.0 $198,229 - $312,708	13,596 New	13,596 $267,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$231 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$147 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$72.2 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$58.6 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account